Antistollingsbehandeling bij patiënten met boezemfibrilleren: afhankelijk van leeftijd en andere risicofactoren voor trombo-embolie

R. Vink; R. B. A. van den Brink; M. [=Marcel M.] Levi

Antistollingsbehandeling bij patiënten met boezemfibrilleren: afhankelijk van leeftijd en andere risicofactoren voor trombo-embolie

Research output: Contribution to journal › Article › Professional

Abstract

Atrial fibrillation is a common arrhythmic disorder which is becoming increasingly prevalent among the elderly. Atrial fibrillation is an independent risk factor for ischaemic stroke. Patients with hypertension, heart failure, diabetes, age older than 65 years, previous thromboembolisms, left atrial enlargement and left ventricular dysfunction have an increased risk. Coumarins (with a target international normalised ratio (INR) of 2.0 to 3.0) are the treatment of first choice in patients with atrial fibrillation. In young patients without additional risk factors, acetyl salicylic acid provides sufficient protection. The management of anticoagulant therapy during electric cardioversion in the acute phase of an ischaemic stroke and during elective surgical interventions, is still a subject of clinical research

Original language	Dutch
Pages (from-to)	2285-2289
Journal	Nederlands tijdschrift voor geneeskunde
Volume	146
Issue number	48
Publication status	Published - 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{0df8748368a54d789a74c8a346bb89ee,

title = "Antistollingsbehandeling bij pati{\"e}nten met boezemfibrilleren: afhankelijk van leeftijd en andere risicofactoren voor trombo-embolie",

abstract = "Atrial fibrillation is a common arrhythmic disorder which is becoming increasingly prevalent among the elderly. Atrial fibrillation is an independent risk factor for ischaemic stroke. Patients with hypertension, heart failure, diabetes, age older than 65 years, previous thromboembolisms, left atrial enlargement and left ventricular dysfunction have an increased risk. Coumarins (with a target international normalised ratio (INR) of 2.0 to 3.0) are the treatment of first choice in patients with atrial fibrillation. In young patients without additional risk factors, acetyl salicylic acid provides sufficient protection. The management of anticoagulant therapy during electric cardioversion in the acute phase of an ischaemic stroke and during elective surgical interventions, is still a subject of clinical research",

author = "R. Vink and \{van den Brink\}, \{R. B. A.\} and Levi, \{M. [=Marcel M.]\}",

year = "2002",

language = "Dutch",

volume = "146",

pages = "2285--2289",

journal = "Nederlands tijdschrift voor geneeskunde",

issn = "0028-2162",

publisher = "Bohn Stafleu Van Loghum",

number = "48",

}

TY - JOUR

T1 - Antistollingsbehandeling bij patiënten met boezemfibrilleren: afhankelijk van leeftijd en andere risicofactoren voor trombo-embolie

AU - Vink, R.

AU - van den Brink, R. B. A.

AU - Levi, M. [=Marcel M.]

PY - 2002

Y1 - 2002

N2 - Atrial fibrillation is a common arrhythmic disorder which is becoming increasingly prevalent among the elderly. Atrial fibrillation is an independent risk factor for ischaemic stroke. Patients with hypertension, heart failure, diabetes, age older than 65 years, previous thromboembolisms, left atrial enlargement and left ventricular dysfunction have an increased risk. Coumarins (with a target international normalised ratio (INR) of 2.0 to 3.0) are the treatment of first choice in patients with atrial fibrillation. In young patients without additional risk factors, acetyl salicylic acid provides sufficient protection. The management of anticoagulant therapy during electric cardioversion in the acute phase of an ischaemic stroke and during elective surgical interventions, is still a subject of clinical research

AB - Atrial fibrillation is a common arrhythmic disorder which is becoming increasingly prevalent among the elderly. Atrial fibrillation is an independent risk factor for ischaemic stroke. Patients with hypertension, heart failure, diabetes, age older than 65 years, previous thromboembolisms, left atrial enlargement and left ventricular dysfunction have an increased risk. Coumarins (with a target international normalised ratio (INR) of 2.0 to 3.0) are the treatment of first choice in patients with atrial fibrillation. In young patients without additional risk factors, acetyl salicylic acid provides sufficient protection. The management of anticoagulant therapy during electric cardioversion in the acute phase of an ischaemic stroke and during elective surgical interventions, is still a subject of clinical research

M3 - Article

C2 - 12497755

SN - 0028-2162

VL - 146

SP - 2285

EP - 2289

JO - Nederlands tijdschrift voor geneeskunde

JF - Nederlands tijdschrift voor geneeskunde

IS - 48

ER -